XL228 T17267
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
XL228 is an inhibitor of multi-targeted tyrosine kinase (IC50s: 5, 3.1, 1.6, 6.1, 2 nM for Bcr-Abl, Aurora A, IGF-1R, Src, and Lyn, respectively).
CAS nr:
898280-07-4
Purity:
98%
Molecular Weight:
437,54
SMILES:
CC(C)c1noc(CNc2nc(N3CCN(C)CC3)cc(Nc3n[nH]c(C4CC4)c3)n2)c1
Formula:
C22H31N9O
Pathway:
Angiogenesis,Tyrosine Kinase/Adaptors,Cell Cycle/Checkpoint,Tyrosine Kinase/Adaptors,Angiogenesis,Chromatin/Epigenetic,Cytoskeletal Signaling,Tyrosine Kinase/Adaptors
Target:
Bcr-Abl,Bcr-Abl,Aurora Kinase,Src,Src,Aurora Kinase,Bcr-Abl,IGF-1R
